Evidence map›Paper›PMID 31749342›Full record

ArticleJournal of Zhejiang University. Science. B

Integrated 3D bioprinting-based geometry-control strategy for fabricating corneal substitutes.

Bin Zhang, Qian Xue, Han-Yi Hu, Meng-Fei Yu, Lei Gao, Yi-Chen Luo, Yang Li, Jin-Tao Li, Liang Ma, Yu-Feng Yao and 1 more

Abstract read
In one paragraph

Article in Journal of Zhejiang University. Science. B. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. 3D Printing Strategies for Bioengineering Human Cornea.Advanced healthcare materials · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Focus on seed cells: stem cells in 3D bioprinting of corneal grafts.Frontiers in bioengineering and biotechnology · 2024
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. 3D Printing in Eye Care.Ophthalmology and therapy · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bin ZhangState Key Laboratory of Fluid Power & Mechatronic Systems, Zhejiang University, Hangzhou 310058, China.
Qian XueState Key Laboratory of Fluid Power & Mechatronic Systems, Zhejiang University, Hangzhou 310058, China.
Han-Yi HuDepartment of Ophthalmology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China.
Meng-Fei YuThe Affiliated Stomatologic Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.
Lei GaoState Key Laboratory of Fluid Power & Mechatronic Systems, Zhejiang University, Hangzhou 310058, China.
Yi-Chen LuoState Key Laboratory of Fluid Power & Mechatronic Systems, Zhejiang University, Hangzhou 310058, China.
Yang LiState Key Laboratory of Fluid Power & Mechatronic Systems, Zhejiang University, Hangzhou 310058, China.
Jin-Tao LiState Key Laboratory of Fluid Power & Mechatronic Systems, Zhejiang University, Hangzhou 310058, China.
Liang MaState Key Laboratory of Fluid Power & Mechatronic Systems, Zhejiang University, Hangzhou 310058, China.
Yu-Feng YaoDepartment of Ophthalmology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China.
Hua-Yong YangState Key Laboratory of Fluid Power & Mechatronic Systems, Zhejiang University, Hangzhou 310058, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe shortage of donor corneas is a severe global issue, and hence the development of corneal alternatives is imperative and urgent. Although attempts to produce artificial cornea substitutes by tissue engineering have made some positive progress, many problems remain that hamper their clinical application worldwide. For example, the curvature of tissue-engineered cornea substitutes cannot be designed to fit the bulbus oculi of patients.

objectiveTo overcome these limitations, in this paper, we present a novel integrated three-dimensional (3D) bioprinting-based cornea substitute fabrication strategy to realize design, customized fabrication, and evaluation of multi-layer hollow structures with complicated surfaces.

methodsThe key rationale for this method is to combine digital light processing (DLP) and extrusion bioprinting into an integrated 3D cornea bioprinting system. A designable and personalized corneal substitute was designed based on mathematical modelling and a computer tomography scan of a natural cornea. The printed corneal substitute was evaluated based on biomechanical analysis, weight, structural integrity, and fit.

resultsThe results revealed that the fabrication of high water content and highly transparent curved films with geometric features designed according to the natural human cornea can be achieved using a rapid, simple, and low-cost manufacturing process with a high repetition rate and quality.

conclusionsThis study demonstrated the feasibility of customized design, analysis, and fabrication of a corneal substitute. The programmability of this method opens up the possibility of producing substitutes for other cornea-like shell structures with different scale and geometry features, such as the glomerulus, atrium, and oophoron.

Indexed as

Artificial OrgansBioprintingPrinting, Three-DimensionalCorneaHumansModels, TheoreticalTensile StrengthTissue EngineeringTissue Scaffolds3D bioprinting; Corneal alternative; Digital light processing (DLP); Extrusion; Geometry-control

Identifiers

PMID31749342
PMCPMC6885410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.